Uchino Junji 内野順治

… Alternative Names

内野順治ウチノジュンジ

UCHINO Junji 内野順治

Less

Researcher Number	80432946
Other IDs
Affiliation (Current)	2025: 京都府立医科大学, 医学(系)研究科(研究院), 准教授
Affiliation (based on the past Project Information) *help	2019 – 2021: 京都府立医科大学, 医学(系)研究科(研究院), 准教授 2011 – 2013: 福岡大学, 医学部, 講師 2008: 九大, 大学病院
Review Section/Research Field	Principal Investigator Respiratory organ internal medicine Except Principal Investigator Basic Section 53030:Respiratory medicine-related / Respiratory organ internal medicine
Keywords	Except Principal Investigator 癌分子標的治療 / ALK / EGFR / がん分子標的治療 / 肺癌 / 薬剤耐性 / 分子標的治療 / 治療抵抗性 / ＨＢ－ＥＧＦ / HB-EGF / 肺線維症

Development of novel therapy and diagnosis targeted for signal transduction regarding drug tolerance in lung cancer
- Principal Investigator
  
  YAMADA TADAAKI
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Kyoto Prefectural University of Medicine
Development of new remedy for pulmonary fibrosis, focused on HB-EGF
- Principal Investigator
  
  FUJITA MASAKI
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Fukuoka University
改変アデノウィルスベクターを用いた癌性胸膜炎の診断Principal Investigator
- Principal Investigator
  
  内野順治
- Project Period (FY)
  2008
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Kyushu University

All 2022 2021 2020

All Journal Article Presentation

[Journal Article] HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.2022
- Author(s)
  Tanimura K, Yamada T, Okada K, Nakai K, Horinaka M, Katayama Y, Morimoto K, Ogura Y, Takeda T, Shiotsu S, Ichikawa K, Watanabe S, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Taniguchi H, Yoneda K, Matoba S, Sakai T, Uehara H, Yano S, Kusaba T, Katayama R, Takayama K.
- Journal Title
  
  NPJ Precis Oncol.
  
  Volume: 6 Issue: 1 Pages: 5-5
- DOI
  10.1038/s41698-021-00250-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08608, KAKENHI-PROJECT-20K21554, KAKENHI-PROJECT-20K22820, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03524, KAKENHI-PROJECT-19H03889, KAKENHI-PROJECT-20K08640
[Journal Article] Inhibition of c-Jun N-terminal kinase signaling increased apoptosis and prevented the emergence of ALK-TKI-tolerant cells in ALK-rearranged non-small cell lung cancer.2021
- Author(s)
  Tanimura K, Yamada T, Horinaka M, Katayama Y, Fukui S, Morimoto K, Nakano T, Tokuda S, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Yoneda K, Yano S, Sakai T, Takayama K.
- Journal Title
  
  Cancer Lett.
  
  Volume: 522 Pages: 119-128
- DOI
  10.1016/j.canlet.2021.09.018
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08608, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03889
[Journal Article] Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer: a prospective observational study.2021
- Author(s)
  Yoshimura A, Yamada T, Okuma Y, Fukuda A, Watanabe S, Nishioka N, Takeda T, Chihara Y, Takemoto S, Harada T, Hiranuma O, Shirai Y, Nishiyama A, Yano S, Goto Y, Shiotsu S, Kunimasa K, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Kenmotsu H, Takahashi T, Takayama K.
- Journal Title
  
  Transl Lung Cancer Res.
  
  Volume: 10 Issue: 8 Pages: 3582-3593
- DOI
  10.21037/tlcr-21-461
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08608
[Journal Article] ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non?Small Cell Lung Cancer2020
- Author(s)
  Okura N, Nishioka N, Yamada T, Taniguchi H, Tanimura K, Katayama Y, Yoshimura A, Watanabe S, Kikuchi T, Shiotsu S, Kitazaki T, Nishiyama A, Iwasaku M, Kaneko Y, Uchino J, Uehara H, Horinaka M, Sakai T, Tanaka K, Kozaki R, Yano S, Takayama K.
- Journal Title
  
  Clinical Cancer Research
  
  Volume: 26 Issue: 9 Pages: 2244-2256
- DOI
  10.1158/1078-0432.ccr-19-2321
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18KT0019, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19K08608, KAKENHI-PROJECT-19H03889, KAKENHI-PROJECT-23K20323
[Presentation] Activation of HER3 signal yields tolerant cells to ALK inhibitors in ALK-rearranged lung cancer2021
- Author(s)
  Keiko Tanimura, Tadaaki Yamada, Kohtaroh Okada, Kazue Yoneda, Junji Uchino, Ryohei Katayama, Koichi Takayama
- Organizer
  第25回アジア太平洋呼吸器学会
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08608

1. TASHIRO Naoki (70613884)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. FUJITA MASAKI (50325461)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. YAMADA TADAAKI (00507048)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
4. 高山浩一 (50274444)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
5. 菊地利明

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. 阿部貴志

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Uchino Junji 内野 順治

内野 順治 ウチノ ジュンジ

UCHINO Junji 内野 順治

Research Projects

Research Products

Co-Researchers

Development of novel therapy and diagnosis targeted for signal transduction regarding drug tolerance in lung cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of new remedy for pulmonary fibrosis, focused on HB-EGF

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

改変アデノウィルスベクターを用いた癌性胸膜炎の診断Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Inhibition of c-Jun N-terminal kinase signaling increased apoptosis and prevented the emergence of ALK-TKI-tolerant cells in ALK-rearranged non-small cell lung cancer.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer: a prospective observational study.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non?Small Cell Lung Cancer2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] Activation of HER3 signal yields tolerant cells to ALK inhibitors in ALK-rearranged lung cancer2021

Author(s)

Organizer

Data Source

Uchino Junji 内野順治

内野順治ウチノジュンジ

UCHINO Junji 内野順治